Skip to main content
. 2010 Nov 10;10:621. doi: 10.1186/1471-2407-10-621

Table 3.

Comparison of DFS among different chemotherapy groups in patients with low TopIIα expression

Chemotherapy regimens Number Median DFS (months) P
Vinorelbine Containing 29 48.16 0.065
Not containing 88 16.23
Gemcitabine Containing 39 14.13 0.530
Not containing 78 22.74
Docetaxel Containing 33 15.74 0.194
Not containing 84 22.74
Paclitaxel Containing 16 22.97 0.990
Not containing 101 18.76